These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38130493)

  • 1. Comparison of Vancomycin Trough-Based and 24-Hour Area Under the Curve Over Minimum Inhibitory Concentration (AUC/MIC)-Based Therapeutic Drug Monitoring in Pediatric Patients.
    Lim WXS; Seah XFV; Thoon KC; Han Z
    J Pediatr Pharmacol Ther; 2023; 28(5):430-438. PubMed ID: 38130493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program.
    Mcgrady KA; Benton M; Tart S; Bowers R
    Pharm Pract (Granada); 2020; 18(3):2024. PubMed ID: 33005260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
    Beccari MV; Seabury RW; Mogle BT; Kufel WD; Miller CD; Steele JM
    J Am Pharm Assoc (2003); 2020; 60(5):729-733. PubMed ID: 32224054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin AUC/MIC and Corresponding Troughs in a Pediatric Population.
    Kishk OA; Lardieri AB; Heil EL; Morgan JA
    J Pediatr Pharmacol Ther; 2017; 22(1):41-47. PubMed ID: 28337080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance-evaluation on an urban health unit.
    Chen M; Lee C; Gnyra M; Wong M
    Ther Adv Infect Dis; 2022; 9():20499361221140368. PubMed ID: 36465428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the Relationship Between Vancomycin Area Under the Concentration Time Curve and Serum Trough Levels in Adults With Presumed or Documented Staphylococcal Infections.
    Clark L; Skrupky LP; Servais R; Brummitt CF; Dilworth TJ
    Ther Drug Monit; 2019 Aug; 41(4):483-488. PubMed ID: 30817704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
    Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
    Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
    Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Drug Monitoring of Vancomycin in Adult Patients with Methicillin-Resistant
    Marko R; Hajjar J; Nzeribe V; Pittman M; Deslandes V; Sant N; Cowan J; Kyermentang K; Ramsay T; Zelenitsky S; Kanji S
    Can J Hosp Pharm; 2021; 74(4):334-343. PubMed ID: 34602621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis.
    Morales Junior R; Tiguman GMB; D'Amaro Juodinis V; Santos ICPF; Leite FS; Vercelino JG; de Lima BD; Barbosa LMG
    Clin Ther; 2022 Sep; 44(9):e91-e96. PubMed ID: 36031477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Vancomycin Dosing to Achieve Target Area Under the Curve in Pediatrics.
    Bosley TE; Kuhn RJ; Gardner B; Autry EB; Fuller M; Overley CL
    J Pediatr Pharmacol Ther; 2021; 26(7):746-752. PubMed ID: 34588940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of Therapeutic Drug Monitoring to Guide Vancomycin Dosing Regimens: Trough Concentration versus Ratio of Area Under the Curve to Minimum Inhibitory Concentration.
    Sault AD; Parent M; Simard C
    Can J Hosp Pharm; 2022; 75(2):89-96. PubMed ID: 35387369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
    Chen Q; Wan J; Shen W; Lin W; Lin X; Huang Z; Lin M; Chen Y
    Pediatr Neonatol; 2022 May; 63(3):247-254. PubMed ID: 35190273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
    Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
    Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.